Association between serum Vitamin B12 levels and the degree of steatosis in patients with nonalcoholic fatty liver disease

Journal of Investigative Medicine

Volumn 59, Issue 7, 2011, Pages 1137-1140

  Koplay, Mustafa ^a   Gulcan, Erim ^b   Ozkan, Fuat ^c  

^a SELCUK UNIVERSITY   (Turkey)

^b DUMLUPINAR UNIVERSITY   (Turkey)

^c KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

Fatty liver disease; Serum vitamin B12 levels; Ultrasonography

Indexed keywords

CYANOCOBALAMIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; LIVER DISEASE; LIVER FUNCTION TEST; MALE; NONALCOHOLIC FATTY LIVER; SERUM; ULTRASOUND; ULTRASOUND TRANSDUCER; VITAMIN BLOOD LEVEL;

EID: 84856716045     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0b013e31822a29f5     Document Type: Article

References (22)

1. Saricam T, Kircali B, Koken T. Assessment of lipid peroxidation and antioxidant capacity in non-alcoholic fatty liver disease. Turk J Gastroenterol. 2005;16:65-70. (Pubitemid 41020235)
2. Ermens AA, Vlasveld LT, Lindemans J. Significance of elevated cobalamin (vitamin B12) levels in blood. Clin Biochem. 2003;36:585-590. (Pubitemid 37434023)
3. Chen AR, Zhang HG, Wang ZP, et al. C-reactive protein, vitamin B12 and C677T polymorphism of N-5,10-methylenetetrahydrofolate reductase gene are related to insulin resistance and risk factors for metabolic syndrome in Chinese population. Clin Invest Med. 2010;33:290-297.
4. Jacobs M, van Greevenbroek MM, van der Kallen CJ, et al. The association between the metabolic syndrome and alanine amino transferase is mediated by insulin resistance via related metabolic intermediates (the Cohort on Diabetes and Atherosclerosis Maastricht study). Metabolism. 2010. Epub ahead of print.
5. Yajima Y, Ohta K, Narui T, et al. Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast. Tohoku J Exp Med. 1983;139:43-50. (Pubitemid 13164807)
6. Hamaguchi M, Kojima T, Itoh Y, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102:2708-2715. (Pubitemid 350179336)
7. Joseph AE, Saverymuttu SH, al-Sam S, et al. Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease. Clin Radiol. 1991;43:26-31.
8. Needleman L, Kurtz AB, Rif kin MD, et al. Sonography of diffuse benign liver disease: accuracy of pattern recognition and grading. AJR Am J Roentgenol. 1986;146:1011-1015. (Pubitemid 16120017)
9. Acikel M, Sunay S, Koplay M, et al. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography. Anadolu Kardiyol Derg. 2009;9:273-279.
10. Wang JT, Liu YL. Non-alcoholic fatty liver disease: the problems we are facing. Hepatobiliary Pancreat Dis Int. 2003;2:334-337.
11. Day CP, James OF. Steatohepatitis: a tale of two ''hits''? Gastroenterology. 1998;114:842-845.
12. Schreuder TC, Verwer BJ, van Nieuwkerk CM, et al. Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol. 2008;14:2474-2486. (Pubitemid 352037734)
13. Volkov I, Press Y, Rudoy I. Vitamin B12 could be a ''master key'' in the regulation of multiple pathological processes. J Nippon Med Sch. 2006;73:65-69.
14. Gulcan E, Toker S, Hatipolu H, et al. Cyanocobalamin may be beneficial in the treatment of recurrent aphthous ulcers even when vitamin B12 levels are normal. Am J Med Sci. 2008;336:379-382.
15. Cylwik B, Czygier M, Daniluk M, et al. Vitamin B12 concentration in the blood of alcoholics. Pol Merkur Lekarski. 2010;28:122-125.
16. Fragasso A, Mannarella C, Ciancio A, et al. Functional vitamin B12 deficiency in alcoholics: an intriguing finding in a retrospective study of megaloblastic anemic patients. Eur J Intern Med. 2010;21:97-100.
17. Holdsworth CD, Atkinson M, Dossett JA, et al. An assessment of the diagnostic and prognostic value of serum vitamin B12 levels in liver disease. Gut. 1964;5:601-606.
18. Kim JA, Montagnani M, Koh KK, et al. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation. 2006;113:1888-1904. (Pubitemid 43739401)
19. Soda R, Tavassoli M, Jacobson DW. Receptor distribution and the endothelial uptake of transcobalamin II in liver cell suspensions. Blood. 1985;65:795-802. (Pubitemid 15115503)
20. Setola E, Monti LD, Galluccio E, et al. Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol. 2004;151:483-489. (Pubitemid 39430267)
21. Mehta SR, Thomas EL, Bell JD, et al. Non-invasive means of measuring hepatic fat content. World J Gastroenterol. 2008;14:3476-3483.
22. Schwenzer NF, Springer F, Schraml C, et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. J Hepatol. 2009;51:433-445.